Improved Detection of Frontotemporal Degeneration May Aid Clinical Trial Efforts, University of Pennsylvania Study

Published: Mar 18, 2013

A series of studies demonstrate improved detection of the second most common form of dementia, providing diagnostic specificity that clears the way for refined clinical trials testing targeted treatments. The new research is being presented by experts from the Perelman School of Medicine at the University of Pennsylvania at the American Academy of Neurology’s 65th Annual Meeting in San Diego March 16-23, 2013.

Back to news